Latest News

Add to Favorites Subscribe Share
newswise-fb-share-

Showing results

110 of 222315
Newswise: 15-Year Study Finds Treatment Gaps Exist for Patients with Peripheral Arterial Disease; More Consistent Use of Life-Saving Medications Recommended
  • Embargo expired:
    17-Nov-2019 4:30 PM EST
Released:
14-Nov-2019 7:05 AM EST
Open in New Tab
Comment
Newswise: Omega-3 Continues to Show Protection Against Heart Disease-Related Death, Without Prostate Cancer Risk
  • Embargo expired:
    17-Nov-2019 3:00 PM EST

Omega-3 Continues to Show Protection Against Heart Disease-Related Death, Without Prostate Cancer Risk

Intermountain Healthcare

Should you take omega-3 pills? Or try to have two to servings of omega-3 rich fish a week, as the American Heart Association recommends? It may seem a bit murky if you follow headlines about nutrition and health. That’s why researchers at the Intermountain Healthcare Heart Institute continue to research the potential benefits and risks of this popular supplement, especially when it comes to prostate cancer risk and heart health.

Channels: All Journal News, Cardiovascular Health, Heart Disease,

Released:
14-Nov-2019 6:30 AM EST
Open in New Tab
Comment
Research Results
Newswise: Researchers Discover New Mutations in Gene Associated with Disease That Causes Weakening of the Heart
  • Embargo expired:
    17-Nov-2019 2:00 PM EST

Researchers Discover New Mutations in Gene Associated with Disease That Causes Weakening of the Heart

Intermountain Healthcare

Researchers from the Intermountain Healthcare Heart Institute in Salt Lake City have identified new mutations in a gene commonly associated with non-ischemic dilated cardiomyopathy (NIDC), a disease that weakens the heart muscle, making it more difficult to adequately circulate blood to meet the body’s needs.

Channels: Cardiovascular Health, Genetics, Heart Disease, Medical Meetings,

Released:
14-Nov-2019 7:05 AM EST
Open in New Tab
Comment
Research Results
Embargo will expire:
18-Nov-2019 11:00 AM EST
Released to reporters:
17-Nov-2019 11:00 AM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 18-Nov-2019 11:00 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Research Results
Newswise: Teens with Heart Disease Improve Exercise Capacity in Large Clinical Trial

Teens with Heart Disease Improve Exercise Capacity in Large Clinical Trial

Children's Hospital of Philadelphia

The largest-ever clinical trial of a medication for pediatric cardiology patients found that an oral drug significantly improved exercise capacity in adolescent patients with severe, congenital single-ventricle heart defects. A study leader says the physiologic benefits represent a milestone in pediatric cardiology.

Channels: Exercise and Fitness, Pharmaceuticals, All Journal News, Cardiovascular Health, Children's Health, Clinical Trials, Heart Disease,

Released:
17-Nov-2019 10:45 AM EST
Open in New Tab
Comment
Announcement
Embargo will expire:
18-Nov-2019 4:00 AM EST
Released to reporters:
17-Nov-2019 4:00 AM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 18-Nov-2019 4:00 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Research Results
Newswise: Diabetes, Heart Problems And Redundant Imaging Scans Are Among Johns Hopkins-Led Performance Improvement Topics on ‘High-Value Care’
  • Embargo expired:
    16-Nov-2019 5:00 PM EST

Diabetes, Heart Problems And Redundant Imaging Scans Are Among Johns Hopkins-Led Performance Improvement Topics on ‘High-Value Care’

Johns Hopkins Medicine

Experts from 80 medical centers in the U.S., Canada and Norway will convene Nov. 15–17 in Baltimore, Maryland, to share best practices and performance improvement initiatives designed to reduce unnecessary tests, treatments and procedures and improve the overall value of health care.

Channels: Cardiovascular Health, Healthcare, Heart Disease, Medical Meetings,

Released:
14-Nov-2019 10:00 AM EST
Open in New Tab
Comment
Research Results
Newswise: Intermittent Fasting Increases Longevity in Cardiac Catheterization Patients
  • Embargo expired:
    16-Nov-2019 4:30 PM EST

Intermittent Fasting Increases Longevity in Cardiac Catheterization Patients

Intermountain Healthcare

In a new study by researchers at the Intermountain Healthcare Heart Institute in Salt Lake City, researchers have found that cardiac catheterization patients who practiced regular intermittent fasting lived longer than patients who don’t.

Channels: Cardiovascular Health, Food Science, Health Food, Healthcare, Nutrition, Public Health, Medical Meetings,

Released:
12-Nov-2019 9:40 AM EST
Open in New Tab
Comment
Research Results
PennMed_logo.png
  • Embargo expired:
    16-Nov-2019 1:30 PM EST

Early Diagnosis of Pregnancy-Associated Heart Disease Linked to Significantly Better Outcomes

Perelman School of Medicine at the University of Pennsylvania

Women who are diagnosed with peripartum cardiomyopathy (PPCM) during late pregnancy or within a month following delivery are more likely to experience restored cardiac function and improved outcomes compared to those who are diagnosed later in the postpartum period.

Channels: All Journal News, Cardiovascular Health, Heart Disease, OBGYN, Race and Ethnicity, Women's Health,

Released:
14-Nov-2019 11:20 AM EST
Open in New Tab
Comment
Research Results
mmc-logo.gif

Experimental cholesterol-lowering drug effective at lowering bad cholesterol, study shows

Mayo Clinic

Twice-yearly injections of an experimental cholesterol-lowering drug, inclisiran, were effective at reducing low-density lipoprotein (LDL) cholesterol, often called bad cholesterol, in patients already taking the maximum dose of statin drugs, according to data of the ORION-10 trial presented Saturday, Nov. 16, at the American Heart Association's Scientific Sessions 2019.

Channels: All Journal News, Cardiovascular Health, Heart Disease, Pharmaceuticals,

Released:
16-Nov-2019 11:55 AM EST
Open in New Tab
Comment
Research Results

Showing results

110 of 222315

Chat now!
5.29984